Home » Topics » Regulatory » Patents

Patents
RSS

Japan Energy describes inhibitors of SMC proliferation

Jan. 22, 1998

New 5-HT1B antagonists developed at SmithKline Beecham

Jan. 22, 1998

New cephems described by Fujisawa

Jan. 22, 1998

Pfizer presents new serotonergic agents

Jan. 22, 1998

Inhibitors of COX-1/COX-2 from Roche

Jan. 22, 1998

Hydroxamic acid-based inhibitors of TNF and/or MMPs under study at Zeneca

Jan. 22, 1998

Merck & Co.'s new HIV protease inhibitors

Jan. 22, 1998

Antiprogestational agents with reduced antiglucocorticoid activity claimed by HHS

Jan. 21, 1998

Duphar presents new vitamin D analogues

Jan. 21, 1998

BMS claims new beta3-adrenoceptor agonists

Jan. 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...